's () Stephen O'Hara talks to Proactive London about their deal with an unnamed US company to manufacture and commercialise a line of its SweetBiotix.
The new partner has been granted an exclusive worldwide licence for the natural alternatives to sugar. In return, it will take on manufacturing and marketing costs of the roll-out and all future expenditure for a number of products.
The identity of the new partner is being kept confidential to protect its launch plans.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE